Case Series Describes Hydroxychloroquine Use, Toxicity in Fabry Disease

Retrieved on: 2021-02-11 15:45:00

Tags for this article:

Clinical medicine

Branches of biology

Medicine

Lysosomal storage diseases

Rare diseases

Lipid storage disorders

Hydroxychloroquine

Quinolines

Fabry disease

Lysosomal storage disease

Alpha-galactosidase

Enzyme replacement therapy

Click the tags to see associated articles and topics

Case Series Describes Hydroxychloroquine Use, Toxicity in Fabry Disease. View article details on hiswai: https://www.empr.com/home/mpr-first-report/worldsymposium-2021/hydroxychloroquine-avoided-in-fabry-disease-increased-toxicity/

Excerpt

Hydroxychloroquine (HCQ) should be avoided in patients with Fabry disease (FD) since its use in these patients can lead to increased toxicity, ...

Article found on: www.empr.com

View Original Article